查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1994094

氣道支架市場：全球市場按產品類型、材料、應用和銷售管道分類的預測 - 2026-2032 年

Airway Stent Market by Product Type, Material, End Use, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，氣道支架市場價值將達到 2.169 億美元，到 2026 年將成長至 2.3133 億美元，到 2032 年將達到 2.912 億美元，複合年成長率為 4.29%。

主要市場統計數據
基準年 2025 2.169億美元
預計年份：2026年 2.3133億美元
預測年份 2032 2.912億美元
複合年成長率 (%) 4.29%

全面的背景概述揭示了臨床需求、設備創新、監管趨勢和不斷變化的採購重點如何重塑氣道支架的決策框架。

氣道支架市場已發展成為一個由臨床需求、技術創新和商業性演變交織而成的複雜體系。本文旨在為決策者提供背景信息，幫助他們權衡不斷變化的患者照護路徑、器械設計方案、監管考慮和分銷趨勢。在從門診中心到三級醫院的所有臨床環境中，氣道支架的說明不僅關注其短期療效，也日益重視其對氣道通暢性、患者生活品質以及後續醫療用途的長期影響。

器械工程的進步、監管預期以及不斷演變的商業化模式，正在從根本上改變氣道支架的競爭格局和部署過程。

近年來，氣道支架領域發生了翻天覆地的變化，不僅改變了競爭動態，也重新定義了相關人員的期望。支架設計的技術進步，例如藥物釋放型機制的整合和自膨脹結構的改進，並非僅僅是漸進式的提升，而是創造了全新的臨床價值。這些材料和工程創新正日益與先進的影像技術、輸送系統以及術前術後通訊協定相結合，共同降低手術操作的差異性，並拓展複雜氣道病變的適應症。

2025 年的關稅環境促使策略供應鏈重組，專注於發展國內製造業，並檢視整個氣道支架生態系統的採購流程。

2025年美國關稅的實施，為氣道支架價值鏈上的相關人員帶來了新的商業性和營運複雜性。關稅帶來的成本壓力迫使製造商重新評估其原料和成品組件的籌資策略，這不僅促使他們採取短期成本削減措施，也促使他們進行長期的供應鏈重組。對於依賴進口金屬、聚合物或成品的公司而言，關稅促使他們重新評估供應商多元化策略，包括探索替代來源和擴大區域採購，以降低對單一國家依賴的風險。

綜合細分洞察揭示了產品類型、材料成分、使用環境和分銷管道如何影響臨床選擇標準、採購行為和商業化路徑。

深入了解市場區隔對於協調產品開發、臨床證據產生和商業策略至關重要。依產品類型分析可知，球囊擴張型、藥物釋放型和自擴張式裝置之間的差異會影響臨床醫生的選擇標準、手術流程和輔助性治療方案。在需要精確控制展開和徑向力的情況下，球囊擴張型裝置通常是首選；而藥物釋放型支架則可透過藥物控制再血管再阻塞風險，因此更需要有關藥物洗脫曲線和全身暴露的證據。另一方面，自擴張式設計則優先考慮在彎曲和動態氣道中的適應性以及長期支架的形成。材料選擇同樣重要。複合材料、金屬和聚合物基結構在機械性質和生物相容性之間各有優劣。在金屬材料中，鈷鉻合金、鎳鈦合金和不銹鋼的彈性、抗疲勞性和滲透性各不頻譜，這會影響輸送系統設計和影像通訊協定。聚合物材料可分為生物相容性聚合物和生物可吸收聚合物。生物相容性聚合物可用於長期支架植入，而生物可吸收聚合物則可在無需永久植入的情況下提供臨時支撐，從而改變了長期後續觀察和安全性方面的考慮。

美洲、歐洲、中東和非洲以及亞太地區的管理體制、採購文化和臨床基礎設施存在差異，因此需要量身定做的部署路徑，這使得戰略性的區域差異化至關重要。

區域趨勢對產品上市、監管路徑和商業策略有顯著影響。在美洲，成熟的臨床基礎設施和一體化的採購組織優先考慮可靠的臨床證據、穩定的供應和成本效益。雖然美國的監管要求和醫院採購慣例側重於長期安全數據和高效的物流，但拉丁美洲市場往往更注重價格合理性和能夠適應不同醫療機構容量的靈活服務模式。因此，希望在美洲尋求商機的公司必須在證據生成和靈活的商業模式之間取得平衡，以應對不同的支付方環境和醫療採購標準。

結合先進設備工程、實證臨床支援和強大商業性能力的公司正在氣道支架領域建立永續的競爭優勢。

氣道支架領域的主要企業正透過整合產品創新、臨床證據投入和卓越商業性執行的整合策略來脫穎而出。一些企業優先進行材料探索和器械架構設計，以提供具有臨床差異化性能特徵的產品，從而解決臨床環境中觀察到的特定失效模式。另一些企業則專注於模組化輸送系統和臨床醫生培訓項目，以降低手術複雜性並提高在任何醫療機構中的可重複性。同時，多家企業正致力於加強上市後證據和註冊登記，以證明其長期治療效果，並爭取被納入主要醫療機構的醫保覆蓋範圍。

醫療設備製造商可採取的策略重點，透過主導創新、彈性供應鏈、客製化商業模式和與支付方合作來加速產品推廣應用。

產業領導企業應採取多管齊下的策略，將創新重點、實證投資和營運韌性結合。首先，他們應優先考慮產品開發路徑，在確保易於給藥和長期生物相容性的同時，解決已證實的臨床失效模式。投資差異化材料科學和給藥機制將有助於在常規和複雜手術中贏得臨床醫生的青睞。其次，他們應制定分階段的臨床證據計劃，從可操作的註冊研究入手，逐步推進到能夠證明臨床顯著差異的比較研究。這些證據將有助於加強採購討論，並促使醫療機構將產品納入醫療設備採購清單。

檢驗可操作的策略推理，該方法結合了對臨床醫生的訪談、採購洞察、監管分析和技術產品審查。

本報告整合了初級和二級調查的調查方法，以全面了解氣道支架的現狀。初級調查的資料來源包括對呼吸科和介入醫學臨床醫生、醫院和門診中心的採購經理以及製造和分銷供應鏈高管的結構化訪談。這些訪談旨在深入了解影響部署決策的裝置性能優先順序、採購標準和營運限制等方面的實際問題。二級調查則透過涵蓋監管指導文件、臨床文獻和產品技術規範，對技術趨勢和安全考量進行了背景分析。

技術、監管和商業性要求的整合決定了哪些組織能夠成功地將氣道支架創新與持久的臨床和組織影響聯繫起來。

總之，氣道支架領域正處於一個關鍵的轉折點，隨著器材創新、臨床證據預期和商業性動態的交匯，其應用路徑正在重新定義。儘管材料和設計的進步拓展了治療選擇，但監管和採購環境越來越依賴基於可驗證的長期療效和價值的論點。定價環境和分銷模式的轉變凸顯了建立具有韌性的供應鏈和靈活的商業化模式的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 氣道支架市場：依產品類型分類

  • 球囊擴張型
  • 藥物釋放型支架
  • 自膨脹

第9章 氣道支架市場：依材料分類

  • 複合材料
  • 金屬
    • 鈷鉻合金
    • 鎳鈦諾
    • 不銹鋼
  • 聚合物
    • 生物相容性聚合物
    • 生物可吸收聚合物

第10章 氣道支架市場：依最終用途分類

  • 門診手術中心
    • 多學科部門
    • 單次治療
  • 診所
    • 循環系統診所
    • 呼吸系統醫療設備
  • 醫院
    • 當地醫院
    • 三級醫療保健

第11章 氣道支架市場：依分銷管道分類

  • 直銷
  • 銷售代理
    • 全國
    • 按地區
  • 電子商務
    • OEM平台
    • 第三方平台

第12章 氣道支架市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 氣道支架市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 氣道支架市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國氣道支架市場

第16章：中國氣道支架市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Allium Medical Solutions Ltd.
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Bryan Corporation
  • BVM Medical Limited
  • Cook Medical
  • Ella-CS
  • EndoFlex GmbH
  • Hood Laboratories
  • Leufen Medical GmbH
  • Medi-Globe Corporation
  • Merit Medical Systems Inc.
  • Micro-Tech Endoscopy Co., Ltd.
  • Novatech SA
  • Olympus Corporation
  • PFM Medical
  • Pnn Medical A/S
  • S&G Biotech
  • Sino Medical Sciences Technology Inc.
  • Stening SRL
  • Taewoong Medical Co., Ltd.
  • Teleflex Incorporated
  • Vascular Concepts Limite
  • WL Gore & Associates, Inc.
Product Code: MRR-1A1A064C03A8

The Airway Stent Market was valued at USD 216.90 million in 2025 and is projected to grow to USD 231.33 million in 2026, with a CAGR of 4.29%, reaching USD 291.20 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 216.90 million
Estimated Year [2026] USD 231.33 million
Forecast Year [2032] USD 291.20 million
CAGR (%) 4.29%

A comprehensive contextual overview clarifying how clinical needs, device innovation, regulatory dynamics, and evolving procurement priorities are reshaping airway stent decision frameworks

The airway stent landscape has matured into a complex intersection of clinical need, technological innovation, and commercial evolution. This introduction sets out the context for decision-makers who must reconcile evolving patient care pathways with device design choices, regulatory considerations, and distribution dynamics. Across clinical settings, from outpatient ambulatory centers to tertiary care hospitals, airway stents are increasingly evaluated not only for immediate procedural outcomes but also for their implications on long-term airway patency, patient quality of life, and downstream care utilization.

In the clinical realm, practitioners are demanding solutions that balance deliverability with durability, biocompatibility with objective efficacy, and tailored performance with streamlined supply chain logistics. Concurrently, materials science is reshaping expectations by enabling devices with enhanced radial force, improved conformability, and, in some cases, controlled drug release profiles. These capabilities are influencing clinician preference and procurement criteria, prompting hospitals and clinics to re-evaluate contracting frameworks and clinical pathways.

From a commercial perspective, manufacturers are navigating a more fragmented purchasing landscape. Distribution models are diversifying, regulatory scrutiny remains elevated, and payer sensitivities are driving more rigorous health-economic conversations. The result is a market environment that rewards clinical differentiation, evidence-based value propositions, and agility in responding to evolving channel strategies. This introduction frames the subsequent analysis by clarifying the essential forces that practitioners, planners, and investors must consider when assessing product development priorities and go-to-market tactics.

How converging advances in device engineering, regulatory expectations, and evolving commercialization models are fundamentally transforming airway stent competitive dynamics and adoption pathways

Over recent years, the airway stent sector has experienced transformative shifts that have altered competitive dynamics and redefined stakeholder expectations. Technological advances in stent design, such as the integration of drug-eluting mechanisms and the refinement of self-expandable architectures, have moved beyond incremental improvements to create new classes of clinical value. These material and engineering innovations are increasingly paired with enhanced imaging, delivery systems, and periprocedural protocols, which together have reduced procedural variability and broadened indications in complex airway pathology.

At the same time, regulatory regimes in key markets have placed a premium on robust clinical evidence and post-market surveillance. This regulatory tightening has elevated the importance of longitudinal outcomes data and has incentivized manufacturers to design studies that demonstrate not only safety but also comparative effectiveness versus established alternatives. Consequently, companies that invest in well-structured clinical programs are gaining enhanced market credibility and stronger positioning with institutional buyers.

Commercial models have evolved in parallel. Distribution channels are becoming more segmented, with direct sales approaches coexisting alongside distributor partnerships and digital platforms. Payers and procurement committees increasingly require transparent cost-effectiveness narratives, and health systems are consolidating purchasing into broader device formularies that favor standardized protocols and trained center-of-excellence networks. In response, firms are prioritizing bundled service offerings, clinician training programs, and data-driven value propositions that align device performance with institutional quality metrics. Overall, the landscape has shifted from product-first competition to ecosystem competition, where clinical evidence, service, and supply reliability are equally decisive.

The 2025 tariff environment has catalyzed strategic supply chain reconfiguration, domestic manufacturing prioritization, and procurement scrutiny across the airway stent ecosystem

The introduction of United States tariffs in 2025 has introduced a discrete layer of commercial and operational complexity for stakeholders across the airway stent value chain. Tariff-induced cost pressures have compelled manufacturers to reassess sourcing strategies for both raw materials and finished components, prompting near-term cost containment measures as well as longer-term supply chain redesigns. For companies reliant on imported metals, polymers, or finished devices, the tariffs have catalyzed a reassessment of supplier diversification, including the exploration of alternative supply bases and increased regional sourcing to mitigate exposure to single-country dependencies.

Supply chain responses have ranged from renegotiated supplier contracts to revisited manufacturing footprints. Some firms accelerated investments in domestic production capabilities to preserve margin and reduce the risk of supply disruptions tied to trade policy volatility. Others absorbed incremental costs in the short term while prioritizing continuity for clinicians and hospitals, relying on pricing and contracting strategies to manage the pass-through of tariff impacts to purchasers. In parallel, procurement teams at hospitals and clinics have intensified scrutiny of total landed cost and supplier risk, incorporating tariff sensitivity into vendor selection and long-term partnership decisions.

Moreover, the tariff environment has influenced strategic partnerships and M&A considerations. Firms with robust in-country manufacturing or diversified global footprints have become more attractive as partners or targets, while pure-play importers faced heightened pressure to demonstrate resilient supply strategies. As a result, the tariff episode has accelerated structural realignments across the industry, with emphasis on operational resilience, flexible sourcing, and transparent cost accounting. For stakeholders, adapting to this environment requires a balanced approach that preserves clinical supply continuity while strategically repositioning procurement, pricing, and production to withstand ongoing geopolitical uncertainty.

Integrated segmentation insights reveal how product type, material composition, end-use environments, and distribution channels shape clinical preference, procurement behavior, and commercialization pathways

A nuanced understanding of market segmentation is essential for aligning product development, clinical evidence generation, and commercial strategies. When analyzed by product type, distinctions among balloon expandable, drug eluting stents, and self expandable devices influence clinician selection criteria, procedural workflows, and adjunctive therapy choices; balloon expandable devices are often favored where controlled deployment and radial force are paramount, drug eluting stents introduce pharmacologic control of restenosis risk and drive evidence needs around elution profiles and systemic exposure, while self expandable designs prioritize conformability and chronic scaffolding in tortuous or dynamic airways. Material choices carry parallel implications: composite, metal, and polymer-based constructions each offer different trade-offs between mechanical performance and biocompatibility. Within metal options, cobalt chromium, nitinol, and stainless steel present a spectrum of elasticity, fatigue resistance, and radiopacity that inform delivery system design and imaging protocols. Polymer options split into biocompatible polymers and bioresorbable polymers, with biocompatible variants often enabling long-term scaffold presence while bioresorbable polymers open pathways for temporary support without permanent implant burden, thereby shifting long-term follow-up and safety considerations.

End-use segmentation further refines go-to-market approaches. Ambulatory surgical centers, clinics, and hospitals create distinct procurement and clinical decision environments: ambulatory surgical centers differentiate into multi-specialty and single procedure models that demand streamlined supply kits and predictable case mix; clinics separate into cardiology and pulmonary specialties, each with unique referral patterns and procedural preferences; hospitals bifurcate into community and tertiary care centers, where community hospitals emphasize cost-effectiveness and ease of use, and tertiary care centers prioritize advanced device features, complex case capability, and robust training support. Distribution channel dynamics interact with these end-use settings, as direct sales, distributors, and e-commerce platforms serve different buyer needs. Distributors operate at national and regional scales and bring logistical reach and value-added services, while e-commerce channels-ranging from OEM platforms to third-party marketplaces-are changing procurement behaviors by offering streamlined ordering, transparent inventory visibility, and alternative pricing models. Integrating these segmentation layers is critical to crafting differentiated product positioning, designing evidence packages that resonate with targeted clinical audiences, and tailoring distribution strategies that match the operational realities of each care setting.

Strategic regional differentiation is essential as distinct regulatory regimes, procurement cultures, and clinical infrastructures across the Americas, EMEA, and Asia-Pacific drive tailored adoption pathways

Regional dynamics exert substantial influence over product adoption, regulatory pathways, and commercial strategies. In the Americas, mature clinical infrastructure and consolidated purchasing organizations drive an emphasis on robust clinical evidence, supply reliability, and cost-effectiveness. U.S. regulatory expectations and hospital procurement practices elevate the value of long-term safety data and streamlined logistics, whereas Latin American markets often prioritize affordability and adaptable service models that account for varying levels of facility capability. Consequently, companies pursuing opportunities in the Americas must balance evidence generation with flexible commercial models that address heterogeneous payer environments and institutional procurement standards.

In Europe, Middle East & Africa, divergent regulatory regimes and healthcare financing models create both challenges and opportunities. Western European markets typically demand rigorous clinical dossiers and have sophisticated hospital networks that value advanced device features and post-market data, while some markets in the Middle East prioritize rapid adoption of proven technologies and offer government-driven procurement pathways. African markets present unique access considerations, including infrastructure limitations and variable regulatory capacity, that favor partnerships, training initiatives, and cost-sensitive offerings. Across EMEA, localization of supply and tailored clinical support programs can materially affect uptake.

The Asia-Pacific region demonstrates heterogeneity driven by rapid technology adoption in some markets and infrastructure variability in others. Countries with advanced tertiary care networks are receptive to innovation and evidence-led adoption, whereas emerging markets emphasize affordability, simplified logistics, and scalable training. Additionally, local manufacturing capabilities and regional trade policies shape sourcing strategies and competitive dynamics. In all regions, cultural nuances in clinician practice patterns and institutional procurement priorities necessitate region-specific value propositions, evidence plans, and distribution models to optimize market penetration and clinical uptake.

Companies that combine advanced device engineering, evidence-based clinical support, and resilient commercial capabilities are securing durable competitive differentiation in the airway stent sector

Leading companies in the airway stent space are distinguishing themselves through integrated strategies that combine product innovation, clinical evidence investment, and commercial execution excellence. Some firms prioritize materials research and device architecture to deliver clinically differentiated performance characteristics that address specific failure modes observed in practice. Others focus on modular delivery systems and clinician training programs that reduce procedural complexity and increase reproducibility across care settings. In parallel, several companies are strengthening post-market evidence and registries to demonstrate long-term outcomes and to support formulary inclusion in major institutions.

Commercially, successful firms are evolving from single-product offerings toward services-oriented models that bundle devices with clinical education, procedural support, and data analytics. This ecosystem approach supports higher adoption in tertiary centers while enabling scaled deployment in ambulatory and community settings. Partnerships with hospital systems and strategic distribution agreements have become pivotal to extending reach and ensuring supply continuity, especially in light of recent trade and tariff dynamics. Moreover, firms that invest in flexible manufacturing footprints and transparent supply chain practices are positioning themselves as lower-risk partners for large health systems and procurement consortia.

In summary, competitive differentiation increasingly rests on the ability to align technical performance with demonstrable clinical value, to operationalize training and support for diverse clinical environments, and to maintain resilient commercial and manufacturing capabilities that satisfy institutional risk and cost criteria.

Actionable strategic priorities for device makers to accelerate adoption through evidence-led innovation, resilient supply chains, tailored commercial models, and payer engagement

Industry leaders should adopt a multi-dimensional strategy that aligns innovation priorities, evidentiary investment, and operational resilience. First, prioritize product development pathways that address documented clinical failure modes while balancing deliverability and long-term biocompatibility. Investing in differentiated material science and delivery mechanisms will help capture clinician preference in both routine and complex procedures. Second, deploy staged clinical evidence programs that begin with pragmatic registries and progress to comparative studies where clinically meaningful differentiation is claimed; these evidence streams will strengthen procurement discussions and support inclusion in institutional device formularies.

Third, reassess supply chain architecture to reduce single-source dependencies and to create redundant capacity where feasible. Strategic investments in regional manufacturing or nearshoring can mitigate tariff exposure and enhance responsiveness. Fourth, tailor commercial models to care settings by offering bundled services and training for tertiary centers while simplifying logistics and kit-based offerings for ambulatory surgical centers and community hospitals. Fifth, embrace digital channels for order management and clinician engagement, ensuring e-commerce platforms and OEM portals improve procurement transparency and inventory reliability.

Finally, cultivate collaborative relationships with payers and clinical leaders to articulate clear value propositions centered on patient outcomes and total cost of care. By combining technical innovation with rigorous evidence, resilient operations, and pragmatic commercial approaches, industry leaders can sustain growth while addressing stakeholder demands across diverse care settings.

A rigorous mixed-methods research approach combining clinician interviews, procurement insights, regulatory analysis, and product technical review to validate actionable strategic inferences

This report synthesizes primary and secondary research methodologies to construct a holistic view of the airway stent landscape. Primary inputs included structured interviews with clinicians across pulmonology and interventional specialties, procurement leaders from hospitals and ambulatory centers, and supply chain executives spanning manufacturing and distribution. These engagements were designed to elicit practical insights on device performance priorities, procurement criteria, and operational constraints that influence adoption decisions. Secondary research encompassed regulatory guidance documents, clinical literature, and product technical specifications to contextualize technological trends and safety considerations.

Analytical techniques incorporated qualitative thematic analysis of stakeholder interviews and cross-sectional comparison of device attributes and clinical evidence. Where applicable, sensitivity analyses explored the operational impact of supply chain variables and tariff scenarios on procurement preferences, while case studies illustrated how leading institutions evaluate and integrate airway stent technologies into care pathways. Throughout the methodology, validity checks were implemented via triangulation across data sources and peer review by clinical advisors to ensure robustness. The approach emphasizes transparent sourcing of insights and careful differentiation between empiric observations and strategic implications so that decision-makers can apply conclusions with confidence.

Synthesis of technical, regulatory, and commercial imperatives that will determine which organizations succeed in translating airway stent innovation into sustained clinical and institutional impact

In conclusion, the airway stent sector is at a pivotal juncture where device innovation, clinical evidence expectations, and commercial dynamics converge to redefine adoption pathways. Advances in materials and design are expanding therapeutic options, while regulatory and procurement environments are increasingly tied to demonstrable long-term outcomes and value-based narratives. The tariff environment and shifting distribution paradigms have underscored the importance of resilient supply chains and flexible commercialization models.

Looking ahead, organizations that integrate targeted product differentiation with pragmatic evidence strategies, regionalized operational resilience, and tailored commercial execution will be best positioned to meet the varied needs of ambulatory centers, clinics, and hospitals. Collaboration across clinical, manufacturing, and procurement stakeholders will be essential to translate technological promise into measurable patient benefit. By focusing on these aligned priorities, manufacturers and institutional partners can navigate current headwinds and unlock sustainable opportunities for improved airway management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Airway Stent Market, by Product Type

  • 8.1. Balloon Expandable
  • 8.2. Drug Eluting Stents
  • 8.3. Self Expandable

9. Airway Stent Market, by Material

  • 9.1. Composite
  • 9.2. Metal
    • 9.2.1. Cobalt Chromium
    • 9.2.2. Nitinol
    • 9.2.3. Stainless Steel
  • 9.3. Polymer
    • 9.3.1. Biocompatible Polymer
    • 9.3.2. Bioresorbable Polymer

10. Airway Stent Market, by End Use

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Multi Specialty
    • 10.1.2. Single Procedure
  • 10.2. Clinics
    • 10.2.1. Cardiology Clinics
    • 10.2.2. Pulmonary Clinics
  • 10.3. Hospitals
    • 10.3.1. Community Hospitals
    • 10.3.2. Tertiary Care

11. Airway Stent Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
    • 11.2.1. National
    • 11.2.2. Regional
  • 11.3. E Commerce
    • 11.3.1. OEM Platforms
    • 11.3.2. Third Party Platforms

12. Airway Stent Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Airway Stent Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Airway Stent Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Airway Stent Market

16. China Airway Stent Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Allium Medical Solutions Ltd.
  • 17.6. Becton Dickinson and Company
  • 17.7. Boston Scientific Corporation
  • 17.8. Bryan Corporation
  • 17.9. BVM Medical Limited
  • 17.10. Cook Medical
  • 17.11. Ella-CS
  • 17.12. EndoFlex GmbH
  • 17.13. Hood Laboratories
  • 17.14. Leufen Medical GmbH
  • 17.15. Medi-Globe Corporation
  • 17.16. Merit Medical Systems Inc.
  • 17.17. Micro-Tech Endoscopy Co., Ltd.
  • 17.18. Novatech SA
  • 17.19. Olympus Corporation
  • 17.20. PFM Medical
  • 17.21. Pnn Medical A/S
  • 17.22. S&G Biotech
  • 17.23. Sino Medical Sciences Technology Inc.
  • 17.24. Stening SRL
  • 17.25. Taewoong Medical Co., Ltd.
  • 17.26. Teleflex Incorporated
  • 17.27. Vascular Concepts Limite
  • 17.28. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AIRWAY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AIRWAY STENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AIRWAY STENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AIRWAY STENT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AIRWAY STENT MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AIRWAY STENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AIRWAY STENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AIRWAY STENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES AIRWAY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA AIRWAY STENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AIRWAY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AIRWAY STENT MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AIRWAY STENT MARKET SIZE, BY BALLOON EXPANDABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AIRWAY STENT MARKET SIZE, BY BALLOON EXPANDABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AIRWAY STENT MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AIRWAY STENT MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AIRWAY STENT MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AIRWAY STENT MARKET SIZE, BY SELF EXPANDABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AIRWAY STENT MARKET SIZE, BY SELF EXPANDABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AIRWAY STENT MARKET SIZE, BY SELF EXPANDABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AIRWAY STENT MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AIRWAY STENT MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AIRWAY STENT MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AIRWAY STENT MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AIRWAY STENT MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AIRWAY STENT MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AIRWAY STENT MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AIRWAY STENT MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AIRWAY STENT MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AIRWAY STENT MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AIRWAY STENT MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AIRWAY STENT MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AIRWAY STENT MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AIRWAY STENT MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AIRWAY STENT MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AIRWAY STENT MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AIRWAY STENT MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AIRWAY STENT MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AIRWAY STENT MARKET SIZE, BY BIOCOMPATIBLE POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AIRWAY STENT MARKET SIZE, BY BIOCOMPATIBLE POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AIRWAY STENT MARKET SIZE, BY BIOCOMPATIBLE POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AIRWAY STENT MARKET SIZE, BY BIORESORBABLE POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AIRWAY STENT MARKET SIZE, BY BIORESORBABLE POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AIRWAY STENT MARKET SIZE, BY BIORESORBABLE POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AIRWAY STENT MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AIRWAY STENT MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AIRWAY STENT MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AIRWAY STENT MARKET SIZE, BY SINGLE PROCEDURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AIRWAY STENT MARKET SIZE, BY SINGLE PROCEDURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AIRWAY STENT MARKET SIZE, BY SINGLE PROCEDURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AIRWAY STENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AIRWAY STENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AIRWAY STENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AIRWAY STENT MARKET SIZE, BY CARDIOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AIRWAY STENT MARKET SIZE, BY CARDIOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AIRWAY STENT MARKET SIZE, BY CARDIOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AIRWAY STENT MARKET SIZE, BY PULMONARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AIRWAY STENT MARKET SIZE, BY PULMONARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AIRWAY STENT MARKET SIZE, BY PULMONARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AIRWAY STENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AIRWAY STENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AIRWAY STENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AIRWAY STENT MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AIRWAY STENT MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AIRWAY STENT MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AIRWAY STENT MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AIRWAY STENT MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AIRWAY STENT MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AIRWAY STENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AIRWAY STENT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AIRWAY STENT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AIRWAY STENT MARKET SIZE, BY NATIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AIRWAY STENT MARKET SIZE, BY NATIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AIRWAY STENT MARKET SIZE, BY NATIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AIRWAY STENT MARKET SIZE, BY REGIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AIRWAY STENT MARKET SIZE, BY REGIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AIRWAY STENT MARKET SIZE, BY REGIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AIRWAY STENT MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AIRWAY STENT MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AIRWAY STENT MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AIRWAY STENT MARKET SIZE, BY OEM PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AIRWAY STENT MARKET SIZE, BY OEM PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AIRWAY STENT MARKET SIZE, BY OEM PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AIRWAY STENT MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AIRWAY STENT MARKET SIZE, BY THIRD PARTY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AIRWAY STENT MARKET SIZE, BY THIRD PARTY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AIRWAY STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS AIRWAY STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL AIRWAY STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 207. GCC AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 208. GCC AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 209. GCC AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 213. GCC AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. GCC AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 243. G7 AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 244. G7 AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 245. G7 AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 247. G7 AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 249. G7 AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. G7 AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 251. G7 AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 252. NATO AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. NATO AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 255. NATO AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 256. NATO AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 257. NATO AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 260. NATO AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. NATO AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES AIRWAY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA AIRWAY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)